OTCMKTS:FPMI

FluoroPharma Medical (FPMI) Stock Price, News & Analysis

$0.0001
0.00 (0.00%)
(As of 05/10/2024 08:56 PM ET)
Today's Range
$0.0001
$0.0001
50-Day Range
N/A
52-Week Range
$0.0001
$0.0002
Volume
5,000 shs
Average Volume
37,500 shs
Market Capitalization
$2,758.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
FPMI stock logo

About FluoroPharma Medical Stock (OTCMKTS:FPMI)

FluoroPharma Medical, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of molecular imaging pharmaceuticals with initial applications in the area of cardiology in the United States. Its product candidates include BFPET, an imaging agent that has completed a Phase I clinical trial in stress-testing for patients with presumptive or proven coronary artery disease (CAD); and CardioPET, a molecular imaging agent, which is in Phase IIa clinical trial to assess myocardial blood flow and metabolism in patients with CAD. The company has license agreements with Massachusetts General Hospital and Sinotau USA; and clinical research agreements with Pharmaceutical Product Development, LLC, as well as Cardiovascular Imaging Technologies. FluoroPharma Medical, Inc. was founded in 2003 and is headquartered in Montclair, New Jersey.

FPMI Stock Price History

FPMI Stock News Headlines

FluoroPharma Medical Inc
Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
FluoroPharma Medical Inc (FPMI)
See More Headlines
Receive FPMI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for FluoroPharma Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/14/2015
Today
5/12/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostic substances
Sub-Industry
N/A
Current Symbol
OTCMKTS:FPMI
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
17,401,000
Market Cap
$3,000.00
Optionable
Not Optionable
Beta
N/A
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Dr. Thomas H. Tulip Ph.D. (Age 71)
    CEO, President & Director
    Comp: $320k
  • Ms. Tamara Rhein (Age 52)
    Chief Financial Officer
    Comp: $130k
  • Mr. Edward L. Lyons Jr.
    Vice President of Development

FPMI Stock Analysis - Frequently Asked Questions

How have FPMI shares performed in 2024?

FluoroPharma Medical's stock was trading at $0.0001 on January 1st, 2024. Since then, FPMI stock has increased by 0.0% and is now trading at $0.0001.
View the best growth stocks for 2024 here
.

How were FluoroPharma Medical's earnings last quarter?

FluoroPharma Medical, Inc. (OTCMKTS:FPMI) announced its earnings results on Friday, August, 14th. The biopharmaceutical company reported ($0.05) earnings per share for the quarter, beating analysts' consensus estimates of ($0.06) by $0.01.

What other stocks do shareholders of FluoroPharma Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other FluoroPharma Medical investors own include Adicet Bio (ACET), AB Corporate Bond ETF (EYEG), Designer Brands (DBI), Capricorn Energy (CNE), Comcast (CMCSA), Casey's General Stores (CASY), Axos Financial (AX) and Argos Therapeutics (ARGSQ).

How do I buy shares of FluoroPharma Medical?

Shares of FPMI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:FPMI) was last updated on 5/13/2024 by MarketBeat.com Staff

From Our Partners